90% of Synlat produced infant formual is actually a2, but yes they will undoubtedly produce a2 above all others now the five year supply agreement is in place.
There is no discrepancy in numerical outlook as A2M have provided no numerical outlook and Synlait have at least provided infant formual growth prospects.
Clearly SM1 reqard the regulatory disruption to be ahead, A2M have no comment on the forward regulatory matters.
90% of Synlat produced infant formual is actually a2, but yes...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.15 |
Change
0.030(0.42%) |
Mkt cap ! $5.168B | |||
| Open | High | Low | Value | Volume |
| $7.14 | $7.18 | $7.12 | $12.98M | 1.815M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 15637 | $7.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.17 | 4741 | 3 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.16 |
Change
0.030 ( 0.65 %) |
||||
| Open | High | Low | Volume | ||
| $7.12 | $7.17 | $7.12 | 574495 | ||
| Last updated 15.59pm 05/06/2024 ? | |||||
| A2M (ASX) Chart |